Skip to main content
    N

    Nephros Inc (NEPH)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.00
    -0.05 (-1.64%)

    Market Cap: $33.15M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Nephros Inc (NEPH) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Nephros reported revenue of $18.79M for the fiscal year ended Dec 31, 2025, up 32.7% from the year before. That year, net income was $1.19M with a net margin of 6.4%, operating cash flow was $1.65M and free cash flow was $1.65M. The quarter ended Sep 30, 2026 had revenue of $5.62M and net income of $512.00K.

    Revenue and Margins

    The operating margin was 6.1% in the fiscal year ended Dec 2025, the highest of the 8 years shown with an operating margin. Over the 9 years to Dec 2025, revenue grew from $2.32M, a compound annual rate of 26.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$18.79M+32.7%61.9%6.1%6.4%
    Dec 2024$14.16M-0.5%61.6%0.0%0.5%
    Dec 2023$14.24M+42.7%59.0%-11.2%-11.1%
    Dec 2022$9.97M-2.4%47.4%-43.5%-71.2%
    Dec 2021$10.22M+19.3%55.1%-31.8%-37.8%
    Dec 2020$8.56MN/A57.4%-49.9%-52.9%
    Dec 2019$0-100.0%N/AN/AN/A
    Dec 2018$5.69M+49.3%56.3%-53.0%-58.5%
    Dec 2017$3.81M+64.2%60.2%-58.4%-21.2%
    Dec 2016$2.32MN/A55.8%-123.7%-130.7%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 1508.1% from the year before. In the quarter ended Sep 2026, net income rose 51.9% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$18.79M$14.16M$14.24M$9.97M$10.22M$8.56M$0$5.69M$3.81M$2.32M
    Cost of revenue$7.16M$5.44M$5.83M$5.24M$4.58M$3.65M-$6.08M$2.48M$1.52M$1.03M
    Gross profit$11.63M$8.72M$8.40M$4.73M$5.63M$4.91M$6.08M$3.20M$2.29M$1.29M
    Research and development$1.34M$906.00K$873.00K$1.25M$1.50M$2.76M$3.09M$1.54M$1.00M$1.08M
    Operating income$1.15M$6.00K-$1.59M-$4.33M-$3.25M-$4.28M-$3.15M-$3.02M-$2.23M-$2.87M
    Net income$1.19M$74.00K-$1.57M-$7.11M-$3.87M-$4.53M-$3.18M-$3.33M-$809.00K-$3.03M
    EBITDA$1.21M$133.00K-$1.42M-$3.92M-$2.98M-$4.22M-$3.01M-$2.85M-$1.97M-$2.58M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$5.62M$6.02M$5.21M$4.73M$4.76M$4.42M$4.88M$3.87M$3.52M$3.25M$3.52M$3.25M
    Gross profit$3.29M$4.03M$2.99M$2.76M$2.92M$2.79M$3.15M$2.48M$2.15M$1.91M$2.19M$2.02M
    Operating income$501.00K$1.21M$97.00K$18.00K$314.00K$248.00K$566.00K$317.00K$206.00K-$317.00K-$200.00K-$649.00K
    Net income$512.00K$1.20M$140.00K$70.00K$337.00K$237.00K$558.00K$318.00K$183.00K-$289.00K-$138.00K-$654.00K
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $391.00K by $5.01M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$13.64M$11.21M$11.86M$11.00M$17.65M$18.51M$11.63M$10.56M$4.98M$2.68M
    Current assets$11.22M$8.30M$8.40M$8.26M$13.63M$15.15M$8.30M$8.17M$3.81M$1.26M
    Cash and equivalents$5.40M$3.76M$4.31M$3.63M$6.97M$8.25M$4.17M$4.58M$2.19M$275.00K
    Total liabilities$3.44M$2.63M$3.50M$2.12M$2.90M$2.94M$3.94M$3.76M$3.03M$2.01M
    Short-term debt$391.00K$348.00K$446.00K$71.00K$248.00K$229.00K$1.07M$1.42M$711.00K$0
    Long-term debtN/AN/AN/A$1.00K$95.00K$846.00K$613.00K$843.00K$954.00K$838.00K
    Shareholder equity$10.20M$8.59M$8.36M$5.59M$11.70M$12.52M$4.67M$3.80M$1.95M$667.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$15.30M$15.77M$13.79M$13.64M$13.25M$12.24M$11.78M$11.21M$10.39M$11.10M$11.42M$11.86M
    Total liabilities$2.76M$3.80M$3.09M$3.44M$3.24M$2.64M$2.49M$2.63M$2.21M$3.17M$3.24M$3.50M
    Cash and equivalents$4.55M$4.70M$4.02M$5.40M$5.17M$5.07M$4.08M$3.76M$2.46M$3.08M$3.63M$4.31M
    Shareholder equity$12.55M$11.97M$10.70M$10.20M$10.01M$9.60M$9.29M$8.59M$8.17M$7.93M$8.18M$8.36M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 100.0% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$1.65M-$492.00K$827.00K-$3.23M-$1.42M-$6.90M-$2.28M-$3.66M-$77.00K-$2.32M
    Capital expenditures$0$55.00K$75.00K$137.00K$36.00K$239.00K$14.00K$0$14.00K$45.00K
    Free cash flow$1.65M-$547.00K$752.00K-$3.37M-$1.45M-$7.14M-$2.29M-$3.66M-$91.00K-$2.36M
    Dividends paidN/AN/AN/A$276.00KN/AN/AN/AN/AN/AN/A
    Investing cash flow$0-$50.00K-$75.00K-$137.00K-$85.00K-$239.00K-$151.00K-$991.00K$0-$45.00K
    Financing cash flow-$5.00K-$5.00K-$79.00K$34.00K$237.00K$11.22M$2.02M$7.05M$1.99M$1.19M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$150.00K$681.00K-$1.67M$230.00K$99.00K$994.00K$322.00K$1.30M-$623.00K-$501.00K-$672.00K-$237.00K
    Capital expendituresN/AN/A$0$0$0$0$0$0$0$55.00K$0$75.00K
    Free cash flowN/AN/A-$1.67M$230.00K$99.00K$994.00K$322.00K$1.30M-$623.00K-$556.00K-$672.00K-$312.00K
    Last 12 quarters

    Frequently Asked Questions About NEPH

    What is Nephros' annual revenue?

    Nephros reported revenue of $18.79M for the fiscal year ended Dec 31, 2025.

    How fast is Nephros' revenue growing?

    Revenue was up 32.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 23.5%.

    Is Nephros profitable?

    Yes. Nephros reported net income of $1.19M for the fiscal year ended Dec 31, 2025, with a net margin of 6.4%.

    How much free cash flow does NEPH generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.65M minus capital expenditures of $0 produced free cash flow of $1.65M.

    How much debt does Nephros have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $391.00K and cash and equivalents of $5.40M.